Rick Wise
Stock Analyst at Stifel Nicolaus
(1.87)
# 3,613
Out of 4,644 analysts
797
Total ratings
51.2%
Success rate
0.1%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintained: Buy | $195 | $183.58 | +6.22% | 33 | Aug 11, 2026 | |
| TMCI Treace Medical Concepts | Maintained: Hold | $3 → $4.5 | $4.75 | -5.26% | 25 | Aug 11, 2026 | |
| AORT Artivion | Reiterated: Buy | $45 | $28.64 | +57.12% | 21 | Aug 7, 2026 | |
| TSX: PRN Profound Medical Corp. | Maintained: Buy | $13.95 | $9.72 | +43.55% | 11 | Aug 7, 2026 | |
| OM Outset Medical | Reiterated: Buy | $6 | $4.50 | +33.33% | 31 | Aug 7, 2026 | |
| ZBH Zimmer Biomet Holdings | Rated: Buy | $105 → $110 | $97.89 | +12.37% | 48 | Aug 6, 2026 | |
| SOLV Solventum | Maintained: Buy | $90 → $100 | $85.29 | +17.25% | 12 | Aug 6, 2026 | |
| MDLN Medline | Rated: Buy | $50 → $45 | $35.50 | +26.76% | 4 | Aug 6, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Buy | $120 | $82.13 | +46.11% | 26 | Aug 5, 2026 | |
| LIVN LivaNova | Maintained: Buy | $80 → $85 | $80.78 | +5.22% | 37 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $24.86 | -3.46% | 33 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $28 | $26.95 | +3.90% | 37 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 | $2.29 | +9.17% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $72.28 | +10.68% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 → $60 | $51.42 | +16.69% | 67 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $43.56 | +14.78% | 35 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $93.05 | +18.22% | 51 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $670 → $550 | $401.27 | +37.06% | 49 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $250 → $260 | $260.86 | -0.33% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $28.00 | +7.14% | 8 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $29.85 | +34.00% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 → $80 | $90.76 | -11.86% | 50 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $440 → $360 | $347.21 | +3.68% | 34 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $120 | $110.91 | +8.20% | 44 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 | $49.48 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.000001 | n/a | 8 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.22 | n/a | 13 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $34 | $23.44 | n/a | 9 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $570.58 | n/a | 2 | Nov 8, 2012 |
Becton, Dickinson and Company
Aug 11, 2026
Maintained: Buy
Price Target: $195
Current: $183.58
Upside: +6.22%
Treace Medical Concepts
Aug 11, 2026
Maintained: Hold
Price Target: $3 → $4.5
Current: $4.75
Upside: -5.26%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $28.64
Upside: +57.12%
Profound Medical Corp.
Aug 7, 2026
Maintained: Buy
Price Target: $13.95
Current: $9.72
Upside: +43.55%
Outset Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $4.50
Upside: +33.33%
Zimmer Biomet Holdings
Aug 6, 2026
Rated: Buy
Price Target: $105 → $110
Current: $97.89
Upside: +12.37%
Solventum
Aug 6, 2026
Maintained: Buy
Price Target: $90 → $100
Current: $85.29
Upside: +17.25%
Medline
Aug 6, 2026
Rated: Buy
Price Target: $50 → $45
Current: $35.50
Upside: +26.76%
LeMaitre Vascular
Aug 5, 2026
Maintained: Buy
Price Target: $120
Current: $82.13
Upside: +46.11%
LivaNova
Aug 5, 2026
Maintained: Buy
Price Target: $80 → $85
Current: $80.78
Upside: +5.22%
Aug 5, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $24.86
Upside: -3.46%
Jul 31, 2026
Maintained: Hold
Price Target: $19 → $28
Current: $26.95
Upside: +3.90%
Jul 30, 2026
Maintained: Buy
Price Target: $2.5
Current: $2.29
Upside: +9.17%
Jul 30, 2026
Maintained: Buy
Price Target: $80
Current: $72.28
Upside: +10.68%
Jul 29, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $51.42
Upside: +16.69%
Jul 24, 2026
Maintained: Buy
Price Target: $50
Current: $43.56
Upside: +14.78%
Jul 24, 2026
Maintained: Buy
Price Target: $110
Current: $93.05
Upside: +18.22%
Jul 17, 2026
Rated: Buy
Price Target: $670 → $550
Current: $401.27
Upside: +37.06%
Jul 15, 2026
Maintained: Hold
Price Target: $250 → $260
Current: $260.86
Upside: -0.33%
Jul 15, 2026
Maintained: Buy
Price Target: $30
Current: $28.00
Upside: +7.14%
Jul 15, 2026
Maintained: Buy
Price Target: $40
Current: $29.85
Upside: +34.00%
Jun 3, 2026
Maintained: Hold
Price Target: $95 → $80
Current: $90.76
Upside: -11.86%
May 1, 2026
Maintained: Buy
Price Target: $440 → $360
Current: $347.21
Upside: +3.68%
Apr 17, 2026
Rated: Buy
Price Target: $145 → $120
Current: $110.91
Upside: +8.20%
May 1, 2025
Maintained: Hold
Price Target: $55
Current: $49.48
Upside: n/a
Jun 3, 2023
Maintained: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Feb 25, 2019
Upgraded: Buy
Price Target: $25 → $30
Current: $2.22
Upside: n/a
Aug 22, 2018
Maintained: Hold
Price Target: $25 → $34
Current: $23.44
Upside: n/a
Nov 8, 2012
Rated: Hold
Price Target: n/a
Current: $570.58
Upside: n/a